Comment on "Ocrelizumab modulates the IL-2 signaling pathway and associated lncRNAs in multiple sclerosis". Sharma A, Kumar P, Morris S. J Neurol Sci 2026;487:125950.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sharma A, Kumar P, Morris S. Comment on "Ocrelizumab modulates the IL-2 signaling pathway and associated lncRNAs in multiple sclerosis". J Neurol Sci 2026;487:125950.
PMID: 42134211